TechMARK movers: Alizyme jumps on licence deal

Related Companies

Related Indices

Related Sectors

News for Spread Betters

PreviousPrevious
NextNext

There's a new Investor Edition of CMC Markets' spread betting platform... and it's exclusive to DigitalLook.com users...

Get full details about Marketmaker:Investor Edition here. Advertisement

Date: Friday 27 Jun 2008

LONDON (ShareCast) - Alizyme rallied on news that it could net up to €42.75m after it granted an exclusive licence to Norgine for the rights to market Colal-Pred, used to treat ulcerative colitis, in Europe, South Africa, Australia and New Zealand.

The UK drug developer will receive £2m upfront and another €40.75m based on the future development and sales milestones.

Gastroenterology-focused Norgine will cover all commercialisation costs and will pay double digit royalty rates to Alizyme that increase with higher annual net sales levels.

Security alarms specialist Visonic expects to report a ‘substantial improvement’ in profit for the six months to 30 June, despite the continuing adverse impact of the strength of the Israeli shekel.

The group said sales in the second quarter of its core business of security and home management are estimated to be up about 19% in comparison with the corresponding period in 2007, with increased sales to almost all its territories and particularly robust growth in Europe.

"I am delighted to report that Visonic's strategy of driving our sales growth through mass market channels, primarily partnerships with leading security and utility companies, is proving successful, as these excellent sales trends show,"said chief executive and president Avigdor Shachrai.

FTSE TechMARK - Risers
Ardana (ARA) 6.50p +30.00%
Alizyme (AZM) 22.25p +7.23%
Visonic (VSC) 53.00p +6.00%
Oxford Biomedica (OXB) 23.25p +5.68%
AEA Technology (AAT) 68.75p +4.17%
Ark Therapeutics (AKT) 55.00p +2.80%
BTG (BGC) 180.50p +2.12%
Renovo Group (RNVO) 40.00p +1.91%
Xaar (XAR) 198.50p +1.79%
ProStrakan (PSK) 79.25p +1.28%

FTSE TechMARK - Fallers
Protherics (PTI) 29.50p -7.09%
Dialight (DIA) 139.00p -6.71%
Emblaze (BLZ) 37.50p -6.25%
Thus Group (THUS) 143.50p -5.28%
Skyepharma (SKP) 6.25p -4.29%
Imagination Technologies (IMG) 70.00p -4.11%
Computacenter (CCC) 129.00p -3.91%
Horizon Technology (HOR) 89.00p -3.78%
Biocompatibles International (BII) 145.00p -3.17%
RM Group (RM.) 185.75p -2.88%

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).